A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact

scientific article published on 18 July 2011

A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/GEPI.20605
P932PMC publication ID3950816
P698PubMed publication ID21769933

P50authorRosalind EelesQ24640445
Gianluca SeveriQ28360445
Graham GilesQ30524411
Dallas R. EnglishQ40580176
Zsofia Kote-JaraiQ42576837
Nicholas Van AsQ42863745
Robert J MacInnisQ44277751
John HopperQ56726496
Ali Amin Al OlamaQ57565560
Douglas F. EastonQ59812154
Michelle GuyQ59832092
Lesley McGuffogQ63233438
Antonis C AntoniouQ89766295
David P DearnaleyQ92184115
Robert HuddartQ94521114
Margaret R E McCredieQ114292608
Vincent KhooQ114365957
Alan HorwichQ114365958
Lynne T O'BrienQ114367560
Emma J SawyerQ114367561
Audrey T. Ardern-JonesQ114387262
P2093author name stringChristopher C Parker
Rosemary A Wilkinson
Amanda L Hall
P2860cites workMortality results from a randomized prostate-cancer screening trialQ24601536
A new look at the statistical model identificationQ26778401
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancerQ28943505
Identification of seven new prostate cancer susceptibility loci through a genome-wide association studyQ29417022
Screening and prostate-cancer mortality in a randomized European studyQ29617485
Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL ConsortiumQ30491647
An approximate model of polygenic inheritanceQ33971299
Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 geneQ34354479
Cancer risks in BRCA2 mutation carriersQ34504452
A systematic review and meta-analysis of familial prostate cancer riskQ35142714
Risk prediction models for familial breast cancerQ36430753
Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancerQ36611191
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotypeQ36614710
Prostate cancer genomics: towards a new understandingQ37292004
Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.Q38426753
Cancer risk prediction models: a workshop on development, evaluation, and applicationQ44065523
Multiple loci on 8q24 associated with prostate cancer susceptibility.Q50582715
The finite polygenic mixed model: An alternative formulation for the mixed model of inheritance.Q52374131
Genome-wide association studies in cancer.Q53316917
Two variants on chromosome 17 confer prostate cancer risk and the one in TCF2 protects against type 2 diabetesQ56968912
Smoking and prostate cancer: Findings from an Australian case-control studyQ56995007
Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studiesQ57265692
Prostate Cancer Progression and Survival in BRCA2 Mutation CarriersQ58143504
Programs for pedigree analysis: Mendel, Fisher, and dGeneQ59760870
Polygenic inheritance of breast cancer: Implications for design of association studiesQ79162761
Cumulative association of five genetic variants with prostate cancerQ80503113
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectprostate cancerQ181257
P304page(s)549-556
P577publication date2011-07-18
P1433published inGenetic EpidemiologyQ5532864
P1476titleA risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact
P478volume35

Reverse relations

cites work (P2860)
Q36959139A personalised approach to prostate cancer screening based on genotyping of risk founder alleles
Q34265269A review of cancer risk prediction models with genetic variants
Q48515655A review of prostate cancer genome wide association studies (GWAS).
Q35848518A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects
Q37623732Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease
Q37138670Association between 17q25.3-rs6465657 polymorphism and prostate cancer susceptibility: a meta-analysis based on 19 studies
Q37474443Biomarkers for prostate cancer: present challenges and future opportunities
Q37148139Biomarkers in prostate cancer epidemiology
Q37002946Cancer Prevention: Obstacles, Challenges and the Road Ahead.
Q33863654Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure: impact of mole phenotype on model performance
Q36394012Diffusion-weighted MRI for detecting prostate tumour in men at increased genetic risk.
Q36388749Evaluating genetic risk for prostate cancer among Japanese and Latinos
Q37650650Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
Q35949522Germline BRCA1 mutations increase prostate cancer risk
Q37474516Germline genetic profiling in prostate cancer: latest developments and potential clinical applications.
Q35146870Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing
Q29417155Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Q47994728Improving Disease Prediction by Incorporating Family Disease History in Risk Prediction Models with Large-Scale Genetic Data
Q37378034Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model
Q27001297Inherited susceptibility for aggressive prostate cancer
Q54938332MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project.
Q53423427Men with a susceptibility to prostate cancer and the role of genetic based screening.
Q38596777Multigene panels in prostate cancer risk assessment: a systematic review
Q35646703Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans
Q36543050Personalized medicine and access to health care: potential for inequitable access?
Q37541989Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes
Q62583133Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q64137885Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test
Q36356727Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q37541290Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk-associated SNPs
Q50175857Prostate Cancer Germline Variations and Implications for Screening and Treatment.
Q34944738Prostate cancer risk prediction based on complete prostate cancer family history
Q46777345Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men.
Q35815958Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci
Q37963657Risk-based prostate cancer screening.
Q37017011The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer
Q38168060The genetic epidemiology of prostate cancer and its clinical implications
Q27025062The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making
Q37633573Using information of relatives in genomic prediction to apply effective stratified medicine.

Search more.